137 related articles for article (PubMed ID: 14517862)
1. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.
Chinen N; Tanihara M; Nakagawa M; Shinozaki K; Yamamoto E; Mizushima Y; Suzuki Y
J Biomed Mater Res A; 2003 Oct; 67(1):61-8. PubMed ID: 14517862
[TBL] [Abstract][Full Text] [Related]
2. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres.
Perets A; Baruch Y; Weisbuch F; Shoshany G; Neufeld G; Cohen S
J Biomed Mater Res A; 2003 Jun; 65(4):489-97. PubMed ID: 12761840
[TBL] [Abstract][Full Text] [Related]
3. Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve.
Ohta M; Suzuki Y; Chou H; Ishikawa N; Suzuki S; Tanihara M; Suzuki Y; Mizushima Y; Dezawa M; Ide C
J Biomed Mater Res A; 2004 Dec; 71(4):661-8. PubMed ID: 15505831
[TBL] [Abstract][Full Text] [Related]
4. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor.
Ho YC; Mi FL; Sung HW; Kuo PL
Int J Pharm; 2009 Jul; 376(1-2):69-75. PubMed ID: 19450670
[TBL] [Abstract][Full Text] [Related]
5. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel.
Jeon O; Kang SW; Lim HW; Hyung Chung J; Kim BS
Biomaterials; 2006 Mar; 27(8):1598-607. PubMed ID: 16146647
[TBL] [Abstract][Full Text] [Related]
6. Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan.
Lee KW; Yoon JJ; Lee JH; Kim SY; Jung HJ; Kim SJ; Joh JW; Lee HH; Lee DS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2464-5. PubMed ID: 15561282
[TBL] [Abstract][Full Text] [Related]
7. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
8. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate.
Tanihara M; Suzuki Y; Yamamoto E; Noguchi A; Mizushima Y
J Biomed Mater Res; 2001 Aug; 56(2):216-21. PubMed ID: 11340591
[TBL] [Abstract][Full Text] [Related]
9. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis.
Kim MS; Bhang SH; Yang HS; Rim NG; Jun I; Kim SI; Kim BS; Shin H
Tissue Eng Part A; 2010 Oct; 16(10):2999-3010. PubMed ID: 20486788
[TBL] [Abstract][Full Text] [Related]
10. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass.
Keshaw H; Forbes A; Day RM
Biomaterials; 2005 Jul; 26(19):4171-9. PubMed ID: 15664644
[TBL] [Abstract][Full Text] [Related]
11. Photo-crosslinkable and biodegradable Pluronic/heparin hydrogels for local and sustained delivery of angiogenic growth factor.
Yoon JJ; Chung HJ; Park TG
J Biomed Mater Res A; 2007 Dec; 83(3):597-605. PubMed ID: 17503533
[TBL] [Abstract][Full Text] [Related]
12. Endothelialization of crosslinked albumin-heparin gels.
Bos GW; Scharenborg NM; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
Thromb Haemost; 1999 Dec; 82(6):1757-63. PubMed ID: 10613666
[TBL] [Abstract][Full Text] [Related]
13. Calcium alginate beads as a slow-release system for delivering angiogenic molecules in vivo and in vitro.
Downs EC; Robertson NE; Riss TL; Plunkett ML
J Cell Physiol; 1992 Aug; 152(2):422-9. PubMed ID: 1379248
[TBL] [Abstract][Full Text] [Related]
14. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor.
Yoon JJ; Chung HJ; Lee HJ; Park TG
J Biomed Mater Res A; 2006 Dec; 79(4):934-42. PubMed ID: 16941589
[TBL] [Abstract][Full Text] [Related]
15. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF.
Pike DB; Cai S; Pomraning KR; Firpo MA; Fisher RJ; Shu XZ; Prestwich GD; Peattie RA
Biomaterials; 2006 Oct; 27(30):5242-51. PubMed ID: 16806456
[TBL] [Abstract][Full Text] [Related]
16. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
17. Heparin-conjugated alginate multilayered microspheres for controlled release of bFGF.
Zuo Q; Guo R; Liu Q; Hong A; Shi Y; Kong Q; Huang Y; He L; Xue W
Biomed Mater; 2015 Jun; 10(3):035008. PubMed ID: 26041143
[TBL] [Abstract][Full Text] [Related]
18. The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model.
Ruvinov E; Leor J; Cohen S
Biomaterials; 2010 Jun; 31(16):4573-82. PubMed ID: 20206988
[TBL] [Abstract][Full Text] [Related]
19. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium.
Gajdusek CM; Carbon S
J Cell Physiol; 1989 Jun; 139(3):570-9. PubMed ID: 2738102
[TBL] [Abstract][Full Text] [Related]
20. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering.
Somers P; Narine K; De Somer F; de Vos F; V Nooten G
Growth Factors; 2008 Oct; 26(5):293-9. PubMed ID: 18651289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
